<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2520-9825</journal-id>
<journal-title><![CDATA[Revista Científica de Salud UNITEPC]]></journal-title>
<abbrev-journal-title><![CDATA[Revista UNITEPC]]></abbrev-journal-title>
<issn>2520-9825</issn>
<publisher>
<publisher-name><![CDATA[Universidad Tecnica Privada Cosmos]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2520-98252023000200008</article-id>
<article-id pub-id-type="doi">10.36716/unitepc.v10i2.627</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Perfil de resistencia antimicrobiana de Escherichia coli y Klebsiella pneumoniae en pacientes que acudieron al Hospital de Norte durante diciembre 2022 - abril 2023.]]></article-title>
<article-title xml:lang="en"><![CDATA[Antimicrobial resistance profile of Escherichia coli and Klebsiella pneumoniae in patients who attended the northern hospital during December 2022 - April 2023.]]></article-title>
<article-title xml:lang="pt"><![CDATA[Perfil de resistência antimicrobiana de Escherichia coli e Klebsiella pneumoniae em pacientes atendidos no hospital do norte durante dezembro de 2022 a abril de 2023.]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[López Mamani]]></surname>
<given-names><![CDATA[Geovana Isabel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Adventista de Bolivia  ]]></institution>
<addr-line><![CDATA[Cochabamba ]]></addr-line>
<country>Bolivia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2023</year>
</pub-date>
<volume>10</volume>
<numero>2</numero>
<fpage>8</fpage>
<lpage>16</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_arttext&amp;pid=S2520-98252023000200008&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_abstract&amp;pid=S2520-98252023000200008&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_pdf&amp;pid=S2520-98252023000200008&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción:  Las infecciones causadas por bacterias resistentes a múltiples antibióticos son un problema mundial. El objetivo de la presente investigación fue determinar el perfil de resistencia antimicrobiana de Escherichia coli y Klebsiella pneumoniae en pacientes que acudieron al Hospital del Norte, Cochabamba - Bolivia. Método: La población estuvo conformada por 134 pacientes. Se incluyeron muestras de orina, esputo, punta de catéter, aspirado traqueal, secreción vaginal, líquido abdominal, absceso, secreción faríngea y secreción escrotal, provenientes de pacientes de ambos sexos y que fueron atendidos entre los meses de diciembre 2022 - abril 2023. El aislamiento e identificación de bacterias se realizó en Agar, Sangre, Mac Conkey, Eosina Azul de Metileno (EMB), pruebas bioquímicas y determinación de resistencia y sensibilidad antibiótica in vitro utilizando el método de disco difusión en agar. Resultados: Los microorganismos que se aislaron con mayor prevalencia fue Escherichia coli con 93,3 %, seguido por Klebsiella pneumoniae con 6,7 %. Ambos microorganismos presentaron mecanismos de resistencia de tipo betalactamasas de espectro extendido (BLEE), betalactamasas de espectro ampliado (BLEA) y serin-betalactamasas (AMPc). Conclusión: La bacteria más aislada fue la Escherichia coli productora de BLEE, BLEA y AMPc, con mayor frecuencia en el sexo femenino. Presentando multirresistencia a los antibióticos cefazolina, ácido Nalidíxico, ciprofloxacina, ampicilina y gentamicina. Y K. pneumoniae presento multirresistencia a cefazolina, ciprofloxacina, ampicilina, cefotaxima y gentamicina.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction:  Infections caused by bacteria resistant to multiple antibiotics are a worldwide problem. The objective of this research was to determine the antimicrobial resistance profile of Escherichia coli and Klebsiella pneumoniae in patients who attended the Hospital del Norte, Cochabamba, Bolivia. Method: The population consisted of 134 patients. Samples of urine, sputum, catheter tip, tracheal aspirate, vaginal secretion, abdominal fluid, abscess, pharyngeal secretion, and scrotal secretion were included, coming from patients of both sexes who were attended between the months of December 2022 and April 2023. Isolation and identification of bacteria were carried out in Agar, blood, Mac Conkey, Eosin Methylene Blue (EMB), biochemical tests and determination of antibiotic resistance and sensitivity in vitro using the agar diffusion disk method. Results: The microorganisms that were isolated with the highest prevalence were Escherichia coli with 93.3%, followed by Klebsiella pneumoniae with 6.7%. Both microorganisms presented extended-spectrum beta-lactamase (ESBL), extended-spectrum beta-lactamase (ESBL) and serine-beta-lactamase (cAMP) resistance mechanisms. Conclusion: The most isolated bacterium was Escherichia coli, which produced ESBL, ESBL and cAMP, more frequently in females. Presenting multi-resistance to the antibiotics cefazolin, nalidixic acid, ciprofloxacin, ampicillin and gentamicin. And K. pneumoniae presented multiresistance to cefazolin, ciprofloxacin, ampicillin, cefotaxime and gentamicin.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo  Introdução:  As infecções causadas por bactérias resistentes a múltiplos antibióticos são um problema mundial. O objetivo desta pesquisa foi determinar o perfil de resistência antimicrobiana de Escherichia coli e Klebsiella pneumoniae em pacientes atendidos no Hospital del Norte, Cochabamba - Bolívia. Método: A população foi composta por 134 pacientes. Foram incluídas amostras de urina, escarro, ponta de cateter, aspirado traqueal, secreção vaginal, líquido abdominal, abscesso, secreção faríngea e secreção escrotal, provenientes de pacientes de ambos os sexos e que foram atendidos entre os meses de dezembro de 2022 a abril de 2023. Isolamento e a identificação da bactéria foi realizada em Ágar, Sangue, Mac Conkey, Eosina Azul de Metileno (EMB), testes bioquímicos e determinação de resistência e sensibilidade a antibióticos in vitro pelo método do disco de difusão em ágar. Resultados: Os microrganismos isolados com maior prevalência foram Escherichia coli com 93,3%, seguido de Klebsiella pneumoniae com 6,7%. Ambos os microrganismos apresentaram mecanismos de resistência à beta-lactamase de espectro estendido (ESBL), beta-lactamase de espectro estendido (ESBL) e serina-beta-lactamase (cAMP). Conclusão: A bactéria mais isolada foi a Escherichia coli, que produziu ESBL, ESBL e cAMP, com maior frequência no sexo feminino. Apresentando multirresistência aos antibióticos cefazolina, ácido nalidíxico, ciprofloxacina, ampicilina e gentamicina. E K. pneumoniae apresentou multirresistência a cefazolina, ciprofloxacina, ampicilina, cefotaxima e gentamicina.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Escherichia coli]]></kwd>
<kwd lng="es"><![CDATA[Klebsiella pneumoniae]]></kwd>
<kwd lng="es"><![CDATA[Betalactamasas de espectro extendido]]></kwd>
<kwd lng="es"><![CDATA[Resistencia]]></kwd>
<kwd lng="en"><![CDATA[Escherichia coli]]></kwd>
<kwd lng="en"><![CDATA[Klebsiella pneumoniae]]></kwd>
<kwd lng="en"><![CDATA[Extended-spectrum beta-lactamases]]></kwd>
<kwd lng="en"><![CDATA[Resistance]]></kwd>
<kwd lng="pt"><![CDATA[Escherichia coli]]></kwd>
<kwd lng="pt"><![CDATA[Klebsiella pneumoniae]]></kwd>
<kwd lng="pt"><![CDATA[Beta-lactamases de espectro estendido]]></kwd>
<kwd lng="pt"><![CDATA[Resistência]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Giono-Cerezo]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Santos-Preciado]]></surname>
<given-names><![CDATA[JI]]></given-names>
</name>
<name>
<surname><![CDATA[Rayo Morfín-Otero]]></surname>
<given-names><![CDATA[M del]]></given-names>
</name>
<name>
<surname><![CDATA[Torres-López]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
<name>
<surname><![CDATA[Alcántar-Curiel]]></surname>
<given-names><![CDATA[MD]]></given-names>
</name>
<name>
<surname><![CDATA[Giono-Cerezo]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Resistencia antimicrobiana. Importancia y esfuerzos por contenerla]]></article-title>
<source><![CDATA[Gac Médica México]]></source>
<year>2020</year>
<volume>156</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>172-80</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carriel Álvarez]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
<name>
<surname><![CDATA[Gerardo Ortiz]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Carriel Álvarez]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
<name>
<surname><![CDATA[Gerardo Ortiz]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia de infección del tracto urinario y perfil de susceptibilidad antimicrobiana en Enterobacterias]]></article-title>
<source><![CDATA[Vive Rev Salud. agosto de]]></source>
<year>2021</year>
<volume>4</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>104-15</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yu]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Han]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Quiñones Pérez]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Yu]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Han]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Quiñones Pérez]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La humanidad enfrenta un desastre: la resistencia antimicrobiana]]></article-title>
<source><![CDATA[Rev Habanera Cienc Médicas]]></source>
<year>2021</year>
<volume>20</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B4">
<label>4.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cabrera Rodríguez]]></surname>
<given-names><![CDATA[LE]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz Rigau]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz Oliva]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Carrasco Miraya]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ortiz García]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Cabrera Rodríguez]]></surname>
<given-names><![CDATA[LE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Multirresistencia de Escherichia coli y Klebsiella pneumoniae provenientes de pacientes con infección del tracto urinario adquirida en la comunidad]]></article-title>
<source><![CDATA[Rev Cuba Med Gen Integral]]></source>
<year>2019</year>
<volume>35</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Castrillón Spitia]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
<name>
<surname><![CDATA[Machado-Alba]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez Idarraga]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez Gutierrez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Remolina León]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Ríos Gallego]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Etiología y perfil de resistencia antimicrobiana en pacientes con infección urinaria]]></article-title>
<source><![CDATA[Infectio]]></source>
<year>2019</year>
<volume>23</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Díaz Velásquez]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Castañeda Torres]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Santa Cruz López]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Carrasco Solano]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Moreno Mantilla]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[etiology of urinary infections and prevalence of Escherichia coli, producer of extended spectrum betalactamases and carbapenemases.]]></article-title>
<source><![CDATA[Rebiol]]></source>
<year>2021</year>
<volume>41</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>179-86</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Toscano]]></surname>
<given-names><![CDATA[YG]]></given-names>
</name>
<name>
<surname><![CDATA[Támara]]></surname>
<given-names><![CDATA[MF]]></given-names>
</name>
<name>
<surname><![CDATA[Urbina]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Rodriguez]]></surname>
<given-names><![CDATA[LG]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[AB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Perfiles de los fenotipos de resistencia en Escherichia coli y Klebsiella pneumoniae en Barranquilla, Colombia]]></article-title>
<source><![CDATA[Rev Cienc Bioméd. 15 de enero de]]></source>
<year>2020</year>
<volume>9</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>15-24</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Escherichia coli portador de betalactamasas de espectro extendido resistencia]]></article-title>
<collab>C M</collab>
<source><![CDATA[Sanid Mil. diciembre de]]></source>
<year>2013</year>
<volume>69</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>244-8</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carriel Álvarez]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
<name>
<surname><![CDATA[Gerardo Ortiz]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia de infección del tracto urinario y perfil de susceptibilidad antimicrobiana en Enterobacterias]]></article-title>
<source><![CDATA[Vive Rev Salud. agosto de]]></source>
<year>2021</year>
<volume>4</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>104-15</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Raraz-Vidal]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Allpas-Gomez]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Raraz-Vidal]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Resistencia antibiótica de Escherichia coli y Staphylococcus saprophyticus en la infección urinaria de un hospital público]]></article-title>
<source><![CDATA[Bol Malariol Salud Ambient]]></source>
<year>2021</year>
<volume>61</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>633-41</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Romero]]></surname>
<given-names><![CDATA[SP]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez]]></surname>
<given-names><![CDATA[MZ]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Pedral]]></surname>
<given-names><![CDATA[MR.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Presencia de ß-lactamasas de espectro extendido en enterobacterias aisladas de casos de infección nosocomial.]]></article-title>
<source><![CDATA[Cienc -Sum]]></source>
<year>2017</year>
<volume>18</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>164-70</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cabrera]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Rigau]]></surname>
<given-names><![CDATA[LD]]></given-names>
</name>
<name>
<surname><![CDATA[Oliva]]></surname>
<given-names><![CDATA[SD]]></given-names>
</name>
<name>
<surname><![CDATA[Miraya]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[GO.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Multirresistencia de Escherichia coli y Klebsiella pneumoniae provenientes de pacientes con infección del tracto urinario adquirida en la comunidad]]></article-title>
<source><![CDATA[Rev Cuba Med Gen Integral]]></source>
<year>2019</year>
<volume>35</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Monté Cepero]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez Casanueva]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Escherichia coli y Klebsiella pneumoniae productoras de betalactamasas de espectro extendido en un hospital de La Habana]]></article-title>
<source><![CDATA[Rev Cuba Hig Epidemiol]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Castellanos]]></surname>
<given-names><![CDATA[TG]]></given-names>
</name>
<name>
<surname><![CDATA[Marshal]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[DS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mecanismos de resistencia a betalactámicos en bacterias gramnegativas]]></article-title>
<source><![CDATA[Rev Cuba Salud Pública]]></source>
<year>2014</year>
<volume>40</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
